SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001586939-14-000003
Filing Date
2014-04-07
Accepted
2014-04-07 12:39:53
Documents
1
Period of Report
2014-04-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9606
  Complete submission text file 0001586939-14-000003.txt   11023
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Issuer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Flynn Peter D (Reporting) CIK: 0001586939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36076 | Film No.: 14748014